Wikidata

(Q62105671)

English

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

clinical trial

In more languages

Statements

title
A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control (English)
0 references
country
Argentina
0 references
Australia
0 references
Brazil
0 references
Canada
0 references
Chile
0 references
India
0 references
Mexico
0 references
Peru
0 references
Philippines
0 references
Taiwan
0 references
Thailand
0 references
Ukraine
0 references
start time
August 2005
0 references
end time
August 2006
0 references
number of participants
1,440
0 references
research intervention
pioglitazone
0 references
glycine
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105671&oldid=2149143778"